<DOC>
	<DOCNO>NCT02433782</DOCNO>
	<brief_summary>Designing treatment protocol use myofascial therapy treatment pain restriction mobility patient hemophilic arthropathy knee ankle . Pilot small number patient assessment effectiveness safety treatment protocol create . Randomized clinical trial ass effectiveness treatment myofascial therapy patient hemophilia . Describe difference term dependent variable ( range motion , pain flexibility ) patient hemophilia carry treatment . Report relationship clinical characteristic patient result obtain treatment period .</brief_summary>
	<brief_title>Myofascial Therapy Patients With Hemophilic Arthropathy</brief_title>
	<detailed_description>Phase I pilot study 5 patient hemophilia assessment myofascial therapy protocol design purpose . Phase II . Randomized , prospective longitudinal clinical study patient hemophilia , assess efficacy intervention myofascial therapy .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patients diagnosis hemophilia A B . Patients older 18 year . Patients diagnosis hemophilic arthropathy knee ankle . Patients prophylactic regimen FVIII / FIX . Patients without walk ability . Patients diagnosis congenital coagulopathy ( eg von Willebrand disease ) . Patients develop antibody FVIII / FIX ( inhibitor ) . Patients neurological cognitive impairment impede understanding questionnaire physical test . Patients sign informed consent document .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Haemophilia</keyword>
	<keyword>Arthropathy</keyword>
	<keyword>Pain</keyword>
	<keyword>Range motion</keyword>
	<keyword>Miofascial technique</keyword>
</DOC>